Pfizer, BioNTech File for Covid-19 Vaccine Approval in Europe


BERLIN—Pfizer Inc. and partner BioNTech SE said they are seeking approval from the European Union for their coronavirus vaccine.

The companies, which have already applied for authorization in the U.S. and U.K., submitted an application on Monday to the European Medicines Agency. That application was accepted on Tuesday by the regulator, the companies said.


Source link